An allogeneic cell therapy company now offering contract manufacturing services is advising advanced therapy manufacturers to diversify and collaborate closely with suppliers, as well as understanding ...

Navigate the complexities of cell and gene therapy (CGT) supply chains with the 6 th Supply Chain & Logistics for Cell & Gene Therapies Summit. The official event guide is your practical roadmap to ...

Biocair, a courier service specializing in serving biotechnology providers, seeks the latest technology for monitoring and visibility of cell and gene-therapy shipments. Few industries manage supply ...

In the biopharmaceutical industry, cell and gene therapy (CGT) emerges as a compelling and rapidly advancing field of medicine. Recent developments include autologous and allogeneic cell therapies and ...

The certification highlights the company’s adherence to rigorous safety and traceability protocols within the cell and gene therapy supply chain.

In the fast-evolving field of cell and gene therapy, overcoming bottlenecks at every stage of the process – both upstream and downstream of manufacturing – is crucial to ensure timely and effective ...

With the launch of Casgevy gaining momentum, Vertex Pharmaceuticals is adding another link to its gene-editing therapy supply chain. Vertex has inked a long-term supply agreement with Swiss ...

CDMOs must now offer platform-based manufacturing, simplified tech transfers, AI-driven automation, and robust analytical services. Speed is also critical—traditional 18–24-month timelines are no ...